Showing results (91-100 of 130) with videos related to
Sort By:
Pageof 13
Medrxiv : the Preprint Server for Health Sciences|February 5, 2024
The Evolutionary History of Metastatic Pancreatic Neuroendocrine Tumours Reveals a Therapy Driven Route to High-Grade TransformationSamuel Backman, Johan Botling, Helena Nord, et al.Lung Cancer (Amsterdam, Netherlands)|December 14, 2020
Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancerHedvig Elfving, Erika Broström, Lotte N J Moens, et al.European Journal of Cancer (Oxford, England : 1990)|March 24, 2023
Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancerMax Backman, Carina Strell, Amanda Lindberg, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validationJohan Botling, Karolina Edlund, Miriam Lohr, et al.The Journal of Pathology|October 3, 2024
The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformationSamuel Backman, Johan Botling, Helena Nord, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 1, 2025
In Situ Detection of Programmed Cell Death Protein 1 and Programmed Death Ligand 1 Interactions as a Functional Predictor for Response to Immune Checkpoint Inhibition in NSCLCAmanda Lindberg, Lars Muhl, Hui Yu, et al.Gut|January 20, 2025
Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolationPanagiota Maravelia, Haidong Yao, Curtis Cai, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 11, 2017
Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parametersMarianna Grinberg, Dijana Djureinovic, Hans Rr Brunnström, et al.Journal of the National Cancer Institute|September 9, 2022
Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune featuresTeijo Pellinen, Lassi Paavolainen, Alfonso Martín-Bernabé, et al.International Journal of Cancer|March 7, 2012
CD99 is a novel prognostic stromal marker in non-small cell lung cancerKarolina Edlund, Cecilia Lindskog, Akira Saito, et al.Pageof 13